75
Participants
Start Date
June 17, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Sacituzumab govitecan
IV infusion of 10 mg/kg on Days 1 and 8 of each continuous and consecutive 21-day cycles. The first infusion will last approximately 3 hours and subsequent infusions will last 1-2 hours if prior infusions were well tolerated.
NOT_YET_RECRUITING
Winship Cancer Institute at Emory University, Atlanta
RECRUITING
Miami Cancer Institute at Baptist Health, Inc., Miami
NOT_YET_RECRUITING
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
Collaborators (1)
Gilead Sciences
INDUSTRY
Reshma L. Mahtani, D.O.
OTHER